Yun Chon
Impact in
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research
- Immunology top 2%
- IL-33, ST2, and ILC Pathways
- Psoriasis: Treatment and Pathogenesis
Papers in
- Hematology 11
- Autoimmune and Inflammatory Disorders Research 10
-
- Vibrio bacteria research studies 5
- Co-authors
- Shao‐Lee LinWilliam W. BusseJingYuan FengEdward KerwinStephen T. HolgateJoseph LinScott W. BaumgartnerSally E. Wenzel
- Journals
- Journal of Allergy and Clinical Immunology (7 papers)The Journal of Rheumatology (3 papers)PLoS neglected tropical diseases (3 papers)Vaccine (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Yun Chon
41 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Hematology 565
- Immunology 950
- Physiology 1.1k
- Immunology and Allergy 199
- Rheumatology 480
Countries citing papers authored by Yun Chon
This map shows the geographic impact of Yun Chon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Chon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Chon more than expected).
Fields of papers citing papers by Yun Chon
This network shows the impact of papers produced by Yun Chon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Chon. The network helps show where Yun Chon may publish in the future.
Co-authors
The 25 scholars most cited alongside Yun Chon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2022 | 6 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 6 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 2 | |
| 7 | 2019 | 9 | |
| 8 | 2018 | 6 | |
| 9 | A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease Hit paper breakdown → | 2016 | 289 |
| 10 | 2015 | 16 | |
| 11 | 2015 | 58 | |
| 12 | Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma Hit paper breakdown → | 2013 | 506 |
| 13 | 2010 | 228 | |
| 14 | 2010 | 91 | |
| 15 | 2010 | 7 | |
| 16 | 2010 | 41 | |
| 17 | 2009 | 139 | |
| 18 | 2009 | 11 | |
| 19 | 2008 | 219 | |
| 20 | 2004 | 15 |
About Yun Chon
Yun Chon is a scholar working on Hematology, Endocrinology, Rheumatology, Speech and Hearing and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (10 papers), Asthma and respiratory diseases (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers), Respiratory and Cough-Related Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Vibrio bacteria research studies (5 papers), Viral gastroenteritis research and epidemiology (5 papers) and Adolescent and Pediatric Healthcare (4 papers). The work is most often cited by research in Hematology (565 citations), Immunology (950 citations), Physiology (1.1k citations), Immunology and Allergy (199 citations) and Rheumatology (480 citations). Yun Chon has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Shao‐Lee Lin, William W. Busse, JingYuan Feng, Edward Kerwin, Stephen T. Holgate, Joseph Lin, Scott W. Baumgartner, Sally E. Wenzel, Edward H. Giannini and Carol A. Wallace. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Rheumatology, PLoS neglected tropical diseases, Vaccine and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.